A semi-quantitative GeLC-MS analysis of temporal proteome expression in the emerging nosocomial pathogen Ochrobactrum anthropi.

PubWeight™: 0.90‹?›

🔗 View Article (PMC 2394761)

Published in Genome Biol on January 01, 2007

Authors

Robert Leslie James Graham1, Mohit K Sharma, Nigel G Ternan, D Brent Weatherly, Rick L Tarleton, Geoff McMullan

Author Affiliations

1: School of Biomedical Sciences, University of Ulster, Coleraine, County Londonderry BT52 1SA, UK. rl.graham@ulster.ac.uk

Articles citing this

iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the interface between physiology and disease. PLoS One (2008) 1.16

Comparative genomics and proteomics of Helicobacter mustelae, an ulcerogenic and carcinogenic gastric pathogen. BMC Genomics (2010) 1.02

Exoproteome of Staphylococcus aureus reveals putative determinants of nasal carriage. J Proteome Res (2011) 0.95

Comparative proteomic analysis of pathogenic and non-pathogenic strains from the swine pathogen Mycoplasma hyopneumoniae. Proteome Sci (2009) 0.87

Comparative transcriptional analysis of clinically relevant heat stress response in Clostridium difficile strain 630. PLoS One (2012) 0.85

Comparative Proteomic Analysis of saccharopolyspora spinosa SP06081 and PR2 strains reveals the differentially expressed proteins correlated with the increase of spinosad yield. Proteome Sci (2011) 0.82

An economical high-throughput protocol for multidimensional fractionation of proteins. Int J Proteomics (2012) 0.80

Comparative proteome analysis of Milnesium tardigradum in early embryonic state versus adults in active and anhydrobiotic state. PLoS One (2012) 0.79

Genomic library screening for viruses from the human dental plaque revealed pathogen-specific lytic phage sequences. Curr Microbiol (2011) 0.78

Semiquantitative analysis of clinical heat stress in Clostridium difficile strain 630 using a GeLC/MS workflow with emPAI quantitation. PLoS One (2014) 0.77

Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseases. Int J Clin Exp Pathol (2008) 0.76

Colonization by endophytic Ochrobactrum anthropi Mn1 promotes growth of Jerusalem artichoke. Microb Biotechnol (2014) 0.75

Articles cited by this

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81

Improved prediction of signal peptides: SignalP 3.0. J Mol Biol (2004) 48.40

The complete general secretory pathway in gram-negative bacteria. Microbiol Rev (1993) 16.84

Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics (2005) 10.67

PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics (2004) 7.15

Expansion of the BioCyc collection of pathway/genome databases to 160 genomes. Nucleic Acids Res (2005) 7.13

The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature (2002) 4.15

Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome. Microbiol Mol Biol Rev (2000) 3.81

Non-classical protein secretion in bacteria. BMC Microbiol (2005) 3.17

Catheter-associated sepsis caused by Ochrobactrum anthropi: report of a case and review of related nonfermentative bacteria. Clin Infect Dis (1992) 2.70

A Heuristic method for assigning a false-discovery rate for protein identifications from Mascot database search results. Mol Cell Proteomics (2005) 2.52

Ochrobactrum anthropi bacteremia: report of four cases and short review. Infection (1994) 2.13

The evolution of chronic infection strategies in the alpha-proteobacteria. Nat Rev Microbiol (2004) 2.13

Evaluation of the relatedness of Brucella spp. and Ochrobactrum anthropi and description of Ochrobactrum intermedium sp. nov., a new species with a closer relationship to Brucella spp. Int J Syst Bacteriol (1998) 2.11

Unconventional genomic organization in the alpha subgroup of the Proteobacteria. J Bacteriol (1998) 2.06

Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells. Blood (2006) 1.92

Large-scale and high-confidence proteomic analysis of human seminal plasma. Genome Biol (2006) 1.84

Thermoadaptation trait revealed by the genome sequence of thermophilic Geobacillus kaustophilus. Nucleic Acids Res (2004) 1.64

Catalytic mechanism of thiol peroxidase from Escherichia coli. Sulfenic acid formation and overoxidation of essential CYS61. J Biol Chem (2003) 1.61

Ochrobactrum anthropi bacteraemia in immunocompetent children. Scand J Infect Dis (2002) 1.60

Intracellular lifestyle of Brucella spp. Common genes with other animal pathogens, plant pathogens, and endosymbionts. Microbes Infect (1999) 1.54

A global analysis of protein expression profiles in Sinorhizobium meliloti: discovery of new genes for nodule occupancy and stress adaptation. Mol Plant Microbe Interact (2003) 1.45

Quantitative proteomic analysis using isobaric protein tags enables rapid comparison of changes in transcript and protein levels in transformed cells. Mol Cell Proteomics (2005) 1.42

In vivo transcription of the Escherichia coli oxyR regulon as a function of growth phase and in response to oxidative stress. J Bacteriol (1999) 1.38

Prosthetic mitral valve endocarditis due to Ochrobactrum anthropi: case report. J Clin Microbiol (2004) 1.37

Thioredoxins in bacteria: functions in oxidative stress response and regulation of thioredoxin genes. Naturwissenschaften (2006) 1.25

Genome reduction in the alpha-Proteobacteria. Curr Opin Microbiol (2005) 1.25

Production of avirulent mutants of Mycobacterium bovis with vaccine properties by the use of illegitimate recombination and screening of stationary-phase cultures. Microbiology (2002) 1.24

Contribution of the Helicobacter pylori thiol peroxidase bacterioferritin comigratory protein to oxidative stress resistance and host colonization. Infect Immun (2005) 1.20

Taxonomic characterization of Ochrobactrum sp. isolates from soil samples and wheat roots, and description of Ochrobactrum tritici sp. nov. and Ochrobactrum grignonense sp. nov. Int J Syst Evol Microbiol (2000) 1.17

A comparison of the consistency of proteome quantitation using two-dimensional electrophoresis and shotgun isobaric tagging in Escherichia coli cells. Electrophoresis (2005) 1.17

Isolation and characterization of diverse halobenzoate-degrading denitrifying bacteria from soils and sediments. Appl Environ Microbiol (2000) 1.11

Early events of Bacillus anthracis germination identified by time-course quantitative proteomics. Proteomics (2006) 1.10

Molecular characterization of chromosomal class C beta-lactamase and its regulatory gene in Ochrobactrum anthropi. Antimicrob Agents Chemother (2001) 1.09

Properties of a novel D-stereospecific aminopeptidase from Ochrobactrum anthropi. J Biol Chem (1989) 1.08

16S ribosomal DNA characterization of nitrogen-fixing bacteria isolated from banana (Musa spp.) and pineapple (Ananas comosus (L.) Merril). Appl Environ Microbiol (2001) 1.07

Proteomic analysis of the oxidative stress response in Candida albicans. Proteomics (2007) 1.07

The role of periplasmic antioxidant enzymes (superoxide dismutase and thiol peroxidase) of the Shiga toxin-producing Escherichia coli O157:H7 in the formation of biofilms. Proteomics (2006) 1.03

Necrotizing fasciitis, bacteremia, and multiorgan failure caused by Ochrobactrum anthropi. Clin Infect Dis (1993) 1.03

Xanthomonas campestris pv. campestris possesses a single gluconeogenic pathway that is required for virulence. J Bacteriol (2005) 1.03

Nodulation of Lupinus albus by strains of Ochrobactrum lupini sp. nov. Appl Environ Microbiol (2005) 1.01

Ochrobactrum pseudintermedium sp. nov., a novel member of the family Brucellaceae, isolated from human clinical samples. Int J Syst Evol Microbiol (2007) 0.99

Gene cloning, nucleotide sequencing, and purification and characterization of the D-stereospecific amino-acid amidase from Ochrobactrum anthropi SV3. Eur J Biochem (2000) 0.98

Bacteremia caused by Ochrobactrum anthropi in an immunocompromised child. Infection (1995) 0.98

Global analysis of the Brucella melitensis proteome: Identification of proteins expressed in laboratory-grown culture. Proteomics (2002) 0.96

The dynamics of the proteome: strategies for measuring protein turnover on a proteome-wide scale. Brief Funct Genomic Proteomic (2005) 0.95

Escherichia coli--a model system that benefits from and contributes to the evolution of proteomics. Biotechnol Bioeng (2003) 0.93

Ochrobactrum anthropi infection of retained pacemaker leads. Clin Infect Dis (1997) 0.91

Proteomics-based analysis of a counter-oxidative stress system in Porphyromonas gingivalis. Proteomics (2006) 0.91

Isolation and identification of a novel strain of the genus Ochrobactrum with phenol-degrading activity. J Biosci Bioeng (2003) 0.91

A novel symbiotic nitrogen-fixing member of the Ochrobactrum clade isolated from root nodules of Acacia mangium. J Gen Appl Microbiol (2004) 0.90

Ochrobactrum cytisi sp. nov., isolated from nodules of Cytisus scoparius in Spain. Int J Syst Evol Microbiol (2007) 0.90

Atypical 16S rRNA gene copies in Ochrobactrum intermedium strains reveal a large genomic rearrangement by recombination between rrn copies. J Bacteriol (2003) 0.89

Modulation of the glutathione S-transferase in Ochrobactrum anthropi: function of xenobiotic substrates and other forms of stress. Biochem J (2000) 0.86

Pulsed-field gel electrophoresis to study the diversity of whole-genome organization in the genus Ochrobactrum. Electrophoresis (2005) 0.86

Shotgun proteomics of cyanobacteria--applications of experimental and data-mining techniques. Brief Funct Genomic Proteomic (2006) 0.86

Brucella proteomes--a review. Vet Microbiol (2002) 0.84

Ochrobactrum tritici strain 5bvl1 - characterization of a Cr(VI)-resistant and Cr(VI)-reducing strain. Can J Microbiol (2004) 0.83

Two new aminopeptidases from Ochrobactrum anthropi active on D-alanyl-p-nitroanilide. Cell Mol Life Sci (1999) 0.83

Multidimensional proteomic analysis of the soluble subproteome of the emerging nosocomial pathogen Ochrobactrum anthropi. J Proteome Res (2006) 0.80

Top-down proteomic analysis of the soluble sub-proteome of the obligate thermophile, Geobacillus thermoleovorans T80: insights into its cellular processes. J Proteome Res (2006) 0.79

Cross-species characterisation of abundantly expressed Ochrobactrum anthropi gene products. Electrophoresis (1999) 0.79

Paraquat resistance of transgenic tobacco plants over-expressing the Ochrobactrum anthropi pqrA gene. Biotechnol Lett (2004) 0.79

Articles by these authors

A Heuristic method for assigning a false-discovery rate for protein identifications from Mascot database search results. Mol Cell Proteomics (2005) 2.52

Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease. Nat Med (2008) 2.04

CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog (2006) 1.93

Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR. Mol Biochem Parasitol (2003) 1.88

Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis (2004) 1.79

In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds. PLoS Negl Trop Dis (2010) 1.72

Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy. Clin Infect Dis (2009) 1.62

Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients. Int Immunol (2006) 1.51

High throughput selection of effective serodiagnostics for Trypanosoma cruzi infection. PLoS Negl Trop Dis (2008) 1.46

Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun (2002) 1.45

Chromosome level assembly of the hybrid Trypanosoma cruzi genome. BMC Genomics (2009) 1.42

Potential new clinical therapies for Chagas disease. Expert Rev Clin Pharmacol (2014) 1.42

CD8+ T cells in Trypanosoma cruzi infection. Curr Opin Immunol (2009) 1.36

The steady-state transcriptome of the four major life-cycle stages of Trypanosoma cruzi. BMC Genomics (2009) 1.33

Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection. J Immunol (2005) 1.33

New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice. J Infect Dis (2013) 1.23

HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease. PLoS Negl Trop Dis (2008) 1.19

Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection. J Immunol (2009) 1.17

Chronic human infection with Trypanosoma cruzi drives CD4+ T cells to immune senescence. J Immunol (2009) 1.12

Widespread, focal copy number variations (CNV) and whole chromosome aneuploidies in Trypanosoma cruzi strains revealed by array comparative genomic hybridization. BMC Genomics (2011) 1.09

Evaluation of high efficiency gene knockout strategies for Trypanosoma cruzi. BMC Microbiol (2009) 1.07

Eliminating Chagas disease: challenges and a roadmap. BMJ (2009) 1.06

A systematic review of high quality diagnostic tests for Chagas disease. PLoS Negl Trop Dis (2012) 1.05

Stable CD8+ T cell memory during persistent Trypanosoma cruzi infection. J Immunol (2008) 1.05

TcruziDB: an integrated, post-genomics community resource for Trypanosoma cruzi. Nucleic Acids Res (2006) 1.05

CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance. J Immunol (2010) 1.02

Comparative genomics and proteomics of Helicobacter mustelae, an ulcerogenic and carcinogenic gastric pathogen. BMC Genomics (2010) 1.02

Cutting edge: dysfunctional CD8+ T cells reside in nonlymphoid tissues during chronic Trypanosoma cruzi infection. J Immunol (2003) 1.02

Cancer cell lines release glutamate into the extracellular environment. Clin Exp Metastasis (2009) 1.00

Methodological advances in drug discovery for Chagas disease. Expert Opin Drug Discov (2011) 0.98

Microarray profiling of gene expression during trypomastigote to amastigote transition in Trypanosoma cruzi. Mol Biochem Parasitol (2003) 0.98

Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection. Vaccine (2003) 0.96

Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease. PLoS One (2012) 0.95

Oral exposure to Trypanosoma cruzi elicits a systemic CD8⁺ T cell response and protection against heterotopic challenge. Infect Immun (2011) 0.94

TGF-beta regulates pathology but not tissue CD8+ T cell dysfunction during experimental Trypanosoma cruzi infection. Eur J Immunol (2007) 0.91

Report of the 2nd Chagas Drug Discovery Consortium meeting, held on 3 November 2010; Atlanta GA, USA. Expert Opin Drug Discov (2011) 0.90

Pseudomonas aeruginosa cystic fibrosis isolates of similar RAPD genotype exhibit diversity in biofilm forming ability in vitro. BMC Microbiol (2010) 0.90

Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice. Infect Immun (2004) 0.89

Evidence for the role of vacuolar soluble pyrophosphatase and inorganic polyphosphate in Trypanosoma cruzi persistence. Mol Microbiol (2013) 0.89

Segmentation of precursor mass range using "tiling" approach increases peptide identifications for MS1-based label-free quantification. Anal Chem (2013) 0.88

Microbial proteomics: a mass spectrometry primer for biologists. Microb Cell Fact (2007) 0.88

TcruziDB: an integrated Trypanosoma cruzi genome resource. Nucleic Acids Res (2004) 0.88

Perpetual expression of PAMPs necessary for optimal immune control and clearance of a persistent pathogen. Nat Commun (2013) 0.88

Comparative transcriptional analysis of clinically relevant heat stress response in Clostridium difficile strain 630. PLoS One (2012) 0.85

Trypanosoma cruzi-specific immune responses in subjects from endemic areas of Chagas disease of Argentina. Microbes Infect (2010) 0.85

Detection of phosphonoacetate degradation and phnA genes in soil bacteria from distinct geographical origins suggest its possible biogenic origin. Environ Microbiol (2006) 0.84

Extracellular glutamate alters mature osteoclast and osteoblast functions. Can J Physiol Pharmacol (2010) 0.84

Quantitative proteomic analysis of the heat stress response in Clostridium difficile strain 630. J Proteome Res (2011) 0.84

Generation of Trypanosoma cruzi-specific CD8+ T-cell immunity is unaffected by the absence of type I interferon signaling. Infect Immun (2010) 0.83

Multidimensional analysis of the insoluble sub-proteome of Oceanobacillus iheyensis HTE831, an alkaliphilic and halotolerant deep-sea bacterium isolated from the Iheya ridge. Proteomics (2007) 0.82

Organophosphonate utilization by the thermophile Geobacillus caldoxylosilyticus T20. Appl Environ Microbiol (2002) 0.82

Proteomics in the microbial sciences. Bioeng Bugs (2011) 0.82

Proteomic analysis of the insoluble subproteome of Clostridium difficile strain 630. FEMS Microbiol Lett (2010) 0.80

Knockout of the dhfr-ts gene in Trypanosoma cruzi generates attenuated parasites able to confer protection against a virulent challenge. PLoS Negl Trop Dis (2011) 0.80

Multidimensional proteomic analysis of the soluble subproteome of the emerging nosocomial pathogen Ochrobactrum anthropi. J Proteome Res (2006) 0.80

Transgenic parasites accelerate drug discovery. Trends Parasitol (2012) 0.80

A role for carbon catabolite repression in the metabolism of phosphonoacetate by Agromyces fucosus Vs2. FEMS Microbiol Lett (2006) 0.79

In vitro and in vivo models of colorectal cancer: antigenotoxic activity of berries. J Agric Food Chem (2014) 0.79

The quantitative proteomic response of Synechocystis sp. PCC6803 to phosphate acclimation. Aquat Biosyst (2013) 0.79

Top-down proteomic analysis of the soluble sub-proteome of the obligate thermophile, Geobacillus thermoleovorans T80: insights into its cellular processes. J Proteome Res (2006) 0.79

Virgin olive oil phenolics extract inhibit invasion of HT115 human colon cancer cells in vitro and in vivo. Food Funct (2014) 0.78

A combined shotgun and multidimensional proteomic analysis of the insoluble subproteome of the obligate thermophile, Geobacillus thermoleovorans T80. J Proteome Res (2006) 0.78

Development of a high-throughput screen targeting caspase-8-mediated cleavage of the amyloid precursor protein. Anal Biochem (2011) 0.78

A by-product of glutathione production in cancer cells may cause disruption in bone metabolic processes. Can J Physiol Pharmacol (2010) 0.77

Trypanoside, anti-tuberculosis, leishmanicidal, and cytotoxic activities of tetrahydrobenzothienopyrimidines. Bioorg Med Chem (2010) 0.77

The human embryonic stem cell proteome revealed by multidimensional fractionation followed by tandem mass spectrometry. Proteomics (2014) 0.75

Identification of antigenic Brugia adult worm proteins by peptide mass fingerprinting. J Parasitol (2009) 0.75

High growth rate and substrate exhaustion results in rapid cell death and lysis in the thermophilic bacterium Geobacillus thermoleovorans. Biotechnol Bioeng (2006) 0.75

Elucidation of trends within venom components from the snake families Elapidae and Viperidae using gel filtration chromatography. Toxicon (2007) 0.75

The composition of potentially bioactive triterpenoid glycosides in red raspberry is influenced by tissue, extraction procedure and genotype. Food Funct (2017) 0.75